The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer.
J Exp Clin Cancer Res
; 36(1): 14, 2017 01 17.
Article
in En
| MEDLINE
| ID: mdl-28095907
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligopeptides
/
Pancreatic Neoplasms
/
Deoxycytidine
/
Azabicyclo Compounds
/
Antimetabolites, Antineoplastic
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
J Exp Clin Cancer Res
Year:
2017
Document type:
Article
Affiliation country:
United States